Search by Drug Name or NDC
NDC 24208-0446-05 Besivance 6 mg/mL Details
Besivance 6 mg/mL
Besivance is a OPHTHALMIC SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is BESIFLOXACIN.
MedlinePlus Drug Summary
Besifloxacin ophthalmic is used to treat bacterial conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeballs and the inside of the eyelids). Besifloxacin is in a class of medications called fluoroquinolones. It works by killing the bacteria that cause infection.
Related Packages: 24208-0446-05Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Besifloxacin Ophthalmic
Product Information
| NDC | 24208-0446 |
|---|---|
| Product ID | 24208-446_2b3a99b3-0edb-428b-ae41-67d297956a65 |
| Associated GPIs | 86101007101820 |
| GCN Sequence Number | 065230 |
| GCN Sequence Number Description | besifloxacin HCl DROPS SUSP 0.6 % OPHTHALMIC |
| HIC3 | Q6W |
| HIC3 Description | OPHTHALMIC ANTIBIOTICS |
| GCN | 24317 |
| HICL Sequence Number | 036350 |
| HICL Sequence Number Description | BESIFLOXACIN HCL |
| Brand/Generic | Brand |
| Proprietary Name | Besivance |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Besifloxacin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 6 |
| Active Ingredient Units | mg/mL |
| Substance Name | BESIFLOXACIN |
| Labeler Name | Bausch & Lomb Incorporated |
| Pharmaceutical Class | Quinolone Antimicrobial [EPC], Quinolones [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022308 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24208-0446-05 (24208044605)
| NDC Package Code | 24208-446-05 |
|---|---|
| Billing NDC | 24208044605 |
| Package | 1 BOTTLE, DROPPER in 1 CARTON (24208-446-05) / 5 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2009-05-28 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 43.4528 |
| Pricing Unit | ML |
| Effective Date | 2024-01-01 |
| NDC Description | BESIVANCE 0.6% SUSP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis